Skip to main navigation

Client Header Links

  • About
    • Board of Directors
    • Founders
    • Leadership
    • Scientific Advisors
  • Platform
    • Technology Overview
    • Publications
  • Pipeline
    • Pipeline Overview
    • ANX005
    • ANX007
  • Investors
    • Overview
    • News Releases
    • Events and Presentations
      • Presentations
    • Corporate Governance
    • Stock Information
    • SEC Filings
    • Shareholder Services
  • Careers
  • Contact
  • Annexon
    Biosciences

Presentations

Investor Relations

Home
Corporate Profile
News Releases
Corporate Governance
Governance Overview
Board of Directors
Leadership
Committee Composition
SEC Filings
Contact IR

Presentations

Corporate Presentation January
Jan 12, 2021

Investor Tools

  • Print
    Print
  • IR Contact
    IR Contact
  • RSS Feeds
    RSS Feeds
  • Email Alerts
    Email Alerts

Quick Links

Quick links

  • Pipeline
  • Platform
  • About
  • Careers
  • Privacy Policy
  • Terms of Use

stop the start of disease

Annexon Biosciences is a clinical-stage biopharmaceutical company developing novel therapies for autoimmune and neurodegenerative diseases, including opthalmic diseases.

Annexon
Biosciences

Social Media

Copyright © 2016 - 2021 Annexon Inc..
All rights reserved.